UniProtKB/Swiss-Prot Q9NZ43: Variant p.Leu154Ser

Vesicle transport protein USE1
Gene: USE1
Feedback?

Variant information Variant position:

154 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant:

LB/B The variants are classified into three categories: LP/P, LB/B and US.

LP/P: likely pathogenic or pathogenic.
LB/B: likely benign or benign.
US: uncertain significance

Residue change:

From Leucine (L) to Serine (S) at position 154 (L154S, p.Leu154Ser). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties:

Change from medium size and hydrophobic (L) to small size and polar (S) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score:

-2 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:

Lowest score: -4 (low probability of substitution).
Highest score: 11 (high probability of substitution).

More information can be found on the following page
Other resources:

Links to websites of interest for the variant.

Variant rs414528 [ dbSNP | Ensembl ]

Sequence information Variant position:

154 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length:

259 The length of the canonical sequence.
Location on the sequence:

EMDVRKRTGVAGSQPVSEKQ L AAELDLVLQRHQNLQEKLAE The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation:

The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         EMDVRKRTGVAGSQPVS-----EKQLAAELDLVLQRHQNLQEKLAE

Mouse                         EVDMRKR-AAKGSRPAD-----ERQSASELDLVLQRHQGLQ

Zebrafish                     ENDLRHR----KSLPVD-----ERQSAAELDQILQHHHNLQ

Caenorhabditis elegans        RSDLRKQLLSSNKHRAQ---------DTSEDQEFMKNELVE

Drosophila                    SDALRRRRGADESSSSSGSANVQETSGENMNQAAKYYTNAQ

Baker's yeast                 VMELRKRLLGKGQNKGL-----GYETTKSVDRQIEDQDTLQ

Fission yeast                 ERELRERQQMSNVEASN-------------AQLLTNQRSMQ

Sequence annotation in neighborhood:

The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:

Type: the type of sequence feature.
Positions: endpoints of the sequence feature.
Description: contains additional information about the feature.

Type	Positions	Description
Chain	1 – 259	Vesicle transport protein USE1
Topological domain	1 – 231	Cytoplasmic
Coiled coil	152 – 231
Alternative sequence	136 – 259	Missing. In isoform 3.
Alternative sequence	147 – 259	Missing. In isoform 2.

Literature citations
Large-scale identification and characterization of human genes that activate NF-kappaB and MAPK signaling pathways.
Matsuda A.; Suzuki Y.; Honda G.; Muramatsu S.; Matsuzaki O.; Nagano Y.; Doi T.; Shimotohno K.; Harada T.; Nishida E.; Hayashi H.; Sugano S.;
Oncogene 22:3307-3318(2003)
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1); VARIANT SER-154; Novel genes expressed in hematopoietic stem/progenitor cells from myelodysplastic syndrome patients.
Zhao M.; Gu J.; Li N.; Peng Y.; Han Z.; Chen Z.;
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1); VARIANT SER-154; The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).
The MGC Project Team;
Genome Res. 14:2121-2127(2004)
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2); VARIANT SER-154;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.